Oita, Japan

Satoshi Ishii

This inventor holds 14 USPTO granted patents. Top assignees: Icahn School of Medicine at Mount Sinai, Amicus Therapeutics, Inc.. Active years: 2001-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satoshi Ishii. Retrieved from https://idiyas.com/inventor/satoshi-ishii-gb9m006r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 2.4

ph-index = 8

Forward Citations = 370(Granted Patents)


Location History:

  • Omichi-machi, JP (2006 - 2013)
  • Oita, JP (2001 - 2016)

Company Filing History:


Years Active: 2001-2016

Loading Chart...
14 patents (USPTO):Explore Patents

Certainly! Here's an article on inventor Satoshi Ishii:

Title: Satoshi Ishii: Pioneering Innovations in Enzyme Therapy

Introduction:

Satoshi Ishii, a visionary inventor hailing from Oita, Japan, has left an indelible mark on the world of medical research and innovation. With a portfolio of 14 patents to his name, Ishii is recognized for his groundbreaking work in enhancing lysosomal enzyme activity for the treatment of genetic disorders such as Fabry and Gaucher diseases. His relentless pursuit of excellence has made him a beacon of inspiration for aspiring inventors worldwide.

Latest Patents:

Ishii's latest patents showcase his expertise in developing novel methods to augment the activity of lysosomal enzymes, particularly in the context of treating rare genetic conditions. His patent on the "Method of enhancing lysosomal α-galactosidase A" demonstrates his innovative approach to combating Fabry disease using compounds like 1-deoxy-galactonojirimycin. Additionally, his "Method for increasing the activity of lysosomal enzymes" focuses on enhancing glucocerebrosidase activity through the administration of imino sugars and related compounds.

Career Highlights:

During his illustrious career, Satoshi Ishii has made significant contributions to the field of enzymology and molecular biology. His tenure at the Mount Sinai School of Medicine of New York University has been marked by groundbreaking research and pioneering discoveries in the realm of genetic therapies. Ishii's innovative approaches have opened new avenues for the treatment of rare genetic disorders, offering hope to patients worldwide.

Collaborations:

In his quest for scientific excellence, Satoshi Ishii has collaborated with esteemed researchers and colleagues, including Jian-Qiang Fan and Naoki Asano. These collaborative efforts have been instrumental in advancing the frontiers of enzyme therapy and genetic medicine, leading to the development of novel treatment modalities for complex diseases.

Conclusion:

In conclusion, Satoshi Ishii's passion for innovation and his unwavering commitment to scientific discovery have positioned him as a trailblazer in the field of genetic medicine. His pioneering work in enhancing lysosomal enzyme activity has laid the groundwork for transformative therapies that hold the potential to revolutionize the treatment of genetic disorders. As a visionary inventor, Ishii's legacy serves as a testament to the power of innovation in shaping a brighter future for generations to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…